1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$370,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA)

Bills named: H.R. 501 (118th)

Medicare/Medicaid MMM

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; Draft legislation to address pharmacy DIR fees; Draft legislation to amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan and Medicare Advantage organizations offering an MA-PD plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1038 (118th), H.R. 1613 (118th)

Pharmacy PHA

H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023; H.R. 382, the Pandemic is Over Act; Draft legislation, Drug Shortage Protection Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 167 (118th), H.R. 382 (118th)

Taxation/Internal Revenue Code TAX

S. 1108, the Death Tax Repeal Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Internal Revenue Service (IRS)

Bills named: S. 1108 (118th)

Labor Issues/Antitrust/Workplace LBR

S. 127, the PBM Transparency Act; S. 113, the Prescription Pricing for the People Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis
MATTHEW SEILER —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 127 (118th), S. 113 (118th)

Defense DEF

TRICARE pharmacy network changes; FY24 NDAA report language to address TRICARE pharmacy network

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

FY24 appropriations language request to fund FTC enforcement of the Robinson-Patman Act; FY24 appropriations report language to address pharmacy compounding; FY24 appropriations report language to address TRICARE pharmacy network

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL New Legislative Aide, Sen. Cynthia Lummis

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.